LHKOREA12

<p><a href="https://www.newsis.com/view/?id=NISX20231115_0002522979&cID=10434&pID=13200" target="_top" class="ke-link">"제약·바이오 글로벌M&A, 상반기만 104조…회복 조짐" :: 공감언론 뉴시스통신사 :: (newsis.com)</a></p><div class="figure-open" contenteditable="false" data-ke-type="opengraph" data-ke-align="alignCenter" data-og-type="website" data-og-title=""제약·바이오 글로벌M&A, 상반기만 104조…회복 조짐"" data-og-description="[서울=뉴시스]황재희 기자 = 올해 상반기 글로벌 제약바이오 분야 M&A(인수합병)가 800억 달러(한화 약 104조원) 이상을 기록하며 회복세를 보인 것으로 나타났다" data-og-host="www.newsis.com" data-og-source-url="https://www.newsis.com/view/?id=NISX20231115_0002522979&cID=10434&pID=13200" data-og-url="https://www.newsis.com/view/?id=NISX20231115_0002522979" data-og-image="https://scrap.kakaocdn.net/dn/ediAQ5/hyUyu6rigJ/3HJEu4nd4AK7UYcK0w8pUk/img.jpg?width=640&height=427&face=0_0_640_427,https://scrap.kakaocdn.net/dn/eDx7q/hyUyy8PmC4/En17xnfTzXRIfkOWG9HP01/img.jpg?width=640&height=427&face=0_0_640_427,https://scrap.kakaocdn.net/dn/1DXRB/hyUyueiAKM/AK8SijM1b9yXG0ydb9rbNK/img.jpg?width=719&height=540&face=0_0_719_540"><a href="https://www.newsis.com/view/?id=NISX20231115_0002522979&cID=10434&pID=13200" target="_blank" data-source-url="https://www.newsis.com/view/?id=NISX20231115_0002522979&cID=10434&pID=13200"><div class="og-image"><img src="https://scrap.kakaocdn.net/dn/ediAQ5/hyUyu6rigJ/3HJEu4nd4AK7UYcK0w8pUk/img.jpg?width=640&height=427&face=0_0_640_427,https://scrap.kakaocdn.net/dn/eDx7q/hyUyy8PmC4/En17xnfTzXRIfkOWG9HP01/img.jpg?width=640&height=427&face=0_0_640_427,https://scrap.kakaocdn.net/dn/1DXRB/hyUyueiAKM/AK8SijM1b9yXG0ydb9rbNK/img.jpg?width=719&height=540&face=0_0_719_540" alt="" xxonerror="this.src="//img1.kakaocdn.net/thumb/C200x200/?fname=https%3A%2F%2Ft1.daumcdn.net%2Fcafe_image%2Fcafe_meta_image_190529.png""></div><div class="og-text"><p class="og-title">"제약·바이오 글로벌M&A, 상반기만 104조…회복 조짐"</p><p class="og-desc">[서울=뉴시스]황재희 기자 = 올해 상반기 글로벌 제약바이오 분야 M&A(인수합병)가 800억 달러(한화 약 104조원) 이상을 기록하며 회복세를 보인 것으로 나타났다</p><p class="og-host">www.newsis.com</p></div></a></div><p> </p>